Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice

被引：12

作者：

Bissery, MC ^{[1
]}

Vrignaud, P ^{[1
]}

Lavelle, F ^{[1
]}

Chabot, GG ^{[1
]}

机构：

[1] INST GUSTAVE ROUSSY, LAB PHARMACOTOXICOL & PHARMACOGENET, CNRS URA 147, F-94805 VILLEJUIF, FRANCE

来源：

CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT | 1996年 / 803卷

关键词：

D O I：

10.1111/j.1749-6632.1996.tb26386.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：173 / 180

页数：8

共 35 条

[1] PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS [J].

ABIGERGES, D ;

CHABOT, GG ;

ARMAND, JP ;

HERAIT, P ;

GOUYETTE, A ;

GANDIA, D .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :210-221

[2] SIMULTANEOUS DETERMINATION OF THE CAMPTOTHECIN ANALOG CPT-11 AND ITS ACTIVE METABOLITE SN-38 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - APPLICATION TO PLASMA PHARMACOKINETIC STUDIES IN CANCER-PATIENTS [J].

BARILERO, I ;

GANDIA, D ;

ARMAND, JP ;

MATHIEUBOUE, A ;

RE, M ;

GOUYETTE, A ;

CHABOT, GG .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 575 (02) :275-280

[3] Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice [J].

Bissery, MC ;

Vrignaud, P ;

Lavelle, F ;

Chabot, GG .

ANTI-CANCER DRUGS, 1996, 7 (04) :437-460

[4]

BISSERY MC, 1992, ANN ONCOL, V3, P82

[5] PHASE-I AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) ADMINISTERED DAILY FOR 3 CONSECUTIVE DAYS EVERY 3 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMORS [J].

CATIMEL, G ;

CHABOT, GG ;

GUASTALLA, JP ;

DUMORTIER, A ;

COTE, C ;

ENGEL, C ;

GOUYETTE, A ;

MATHIEUBOUE, A ;

MAHJOUBI, M ;

CLAVEL, M .

ANNALS OF ONCOLOGY, 1995, 6 (02) :133-140

[6] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN (CPT-11) AND ACTIVE METABOLITE SN-38 DURING PHASE-I TRIALS [J].

CHABOT, GG ;

ABIGERGES, D ;

CATIMEL, G ;

CULINE, S ;

DEFORNI, R ;

EXTRA, JM ;

MAHJOUBI, H ;

HERAIT, P ;

ARMAND, JP ;

BUGAT, R ;

CLAVEL, M ;

MARTY, ME .

ANNALS OF ONCOLOGY, 1995, 6 (02) :141-151

[7]

CORBETT TH, 1989, INVEST NEW DRUG, V7, P37

[8]

CORBETT TH, 1985, IN VITRO IN VIVO MOD, P5

[9]

CORBETT TH, 1982, CANCER RES, V42, P1701

[10]

DEFORNI M, 1994, CANCER RES, V54, P4347

← 1 2 3 4 →